Aperio Group’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-14,267
Closed -$105K 2339
2019
Q3
$105K Buy
14,267
+3,972
+39% +$28.4K ﹤0.01% 2237
2019
Q2
$83K Sell
10,295
-153
-1% -$1.53K ﹤0.01% 2436
2019
Q1
$118K Sell
10,448
-2,401
-19% -$30.2K ﹤0.01% 2230
2018
Q4
$126K Sell
12,849
-79
-0.6% -$1.06K ﹤0.01% 2202
2018
Q3
$213K Sell
12,928
-755
-6% -$12K ﹤0.01% 2165
2018
Q2
$204K Sell
13,683
-1,810
-12% -$30.3K ﹤0.01% 2163
2018
Q1
$266K Buy
15,493
+1,178
+8% +$18.4K ﹤0.01% 2013
2017
Q4
$173K Buy
+14,315
New +$137K ﹤0.01% 2161

Other funds holding SGRY

Aperio Group's SGRY Position: Q4 2019 in Review

Aperio Group sold out of Surgery Partners (SGRY) in Q4 2019, closing a stake of 14,267 shares — an estimated $105K sold.

Aperio Group first reported a position in SGRY in Q4 2017 and held it in 8 quarters. The position peaked at $266K in Q1 2018. 98 funds tracked by Wall St. Rank hold SGRY as of Q4 2019.

  • Aperio Group reported no remaining Surgery Partners position as of Q4 2019 after selling out during the quarter.
  • Aperio Group sold 14,267 Surgery Partners shares in Q4 2019, an estimated $105K.
  • Aperio Group first reported a position in Surgery Partners in Q4 2017 and held it in 8 quarters.
  • Aperio Group's Surgery Partners position peaked at $266K in Q1 2018.
  • 98 funds tracked by Wall St. Rank held Surgery Partners as of Q4 2019.

Based on Aperio Group's 13F filing for Q4 2019, filed 13 Feb 2020.